Opus Genetics, Inc. Prepaid Expense and Other Assets
Opus Genetics, Inc. (IRD) had Prepaid Expense and Other Assets of $901.30 thousand as of 2014-06-30, per its 10-Q filed 2014-08-13.
Discontinued › Balance Sheet › Assets
us-gaap:PrepaidExpenseAndOtherAssets · last filed 2014-08-13
- 2014-06-30: Prepaid Expense and Other Assets $901.30K.
- 2014-03-31: Prepaid Expense and Other Assets $725.47K.
- 2013-12-31: Prepaid Expense and Other Assets $507.17K.
- 2013-09-30: Prepaid Expense and Other Assets $523.12K.
| Period end | Prepaid Expense and Other Assets |
|---|---|
| 2014-06-30 | $901.30K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $725.47K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $507.17K 10-Q · filed 2014-08-13 |
| 2013-09-30 | $523.12K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $390.67K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $183.32K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $188.81K 10-K · filed 2014-03-21 |
| 2012-09-30 | $218.03K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $333.90K 10-Q · filed 2012-08-08 |
| 2012-03-31 | $287.25K 10-Q · filed 2012-05-09 |
| 2011-12-31 | $333.17K 10-K · filed 2013-03-22 |
| 2011-09-30 | $455.71K 10-Q · filed 2011-11-09 |
| 2011-06-30 | $486.10K 10-Q · filed 2011-08-09 |
| 2010-12-31 | $706.65K 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |